154 related articles for article (PubMed ID: 36497152)
1. Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing
Kim SH; Go EM; Shin DH; Choi BK; Han C
Cells; 2022 Dec; 11(23):. PubMed ID: 36497152
[TBL] [Abstract][Full Text] [Related]
2. Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma.
Kodumudi KN; Weber A; Sarnaik AA; Pilon-Thomas S
J Immunol; 2012 Dec; 189(11):5147-54. PubMed ID: 23100512
[TBL] [Abstract][Full Text] [Related]
3. Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.
Wittling MC; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Cole AC; Lesinski GB; Paulos CM
J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38945552
[TBL] [Abstract][Full Text] [Related]
4. Effective adoptive transfer of haploidentical tumor-specific T cells in B16-melanoma bearing mice.
Cui NP; Xie SJ; Han JS; Ma ZF; Chen BP; Cai JH
Chin Med J (Engl); 2012 Mar; 125(5):794-800. PubMed ID: 22490577
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα
Kim SH; Cho E; Kim YI; Han C; Choi BK; Kwon BS
Nat Commun; 2021 Sep; 12(1):5314. PubMed ID: 34493727
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma.
Wallen H; Thompson JA; Reilly JZ; Rodmyre RM; Cao J; Yee C
PLoS One; 2009; 4(3):e4749. PubMed ID: 19270751
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.
Rubinstein MP; Cloud CA; Garrett TE; Moore CJ; Schwartz KM; Johnson CB; Craig DH; Salem ML; Paulos CM; Cole DJ
J Am Coll Surg; 2012 Apr; 214(4):700-7; discussion 707-8. PubMed ID: 22360982
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.
Bowers JS; Nelson MH; Kundimi S; Bailey SR; Huff LW; Schwartz KM; Cole DJ; Rubinstein MP; Paulos CM
Clin Cancer Res; 2015 Jun; 21(11):2546-57. PubMed ID: 25904754
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
Tseng J; Citrin DE; Waldman M; White DE; Rosenberg SA; Yang JC
Cancer; 2014 May; 120(9):1426-32. PubMed ID: 24474396
[TBL] [Abstract][Full Text] [Related]
10. In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes.
Zheng Y; Stephan MT; Gai SA; Abraham W; Shearer A; Irvine DJ
J Control Release; 2013 Dec; 172(2):426-35. PubMed ID: 23770010
[TBL] [Abstract][Full Text] [Related]
11. A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy.
Cho HI; Reyes-Vargas E; Delgado JC; Celis E
Cancer Res; 2012 Apr; 72(8):1986-95. PubMed ID: 22367213
[TBL] [Abstract][Full Text] [Related]
12. Low-dose total body irradiation facilitates antitumoral Th1 immune responses.
Sonanini D; Griessinger CM; Schörg BF; Knopf P; Dittmann K; Röcken M; Pichler BJ; Kneilling M
Theranostics; 2021; 11(16):7700-7714. PubMed ID: 34335959
[TBL] [Abstract][Full Text] [Related]
13. Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cells.
Wang LX; Shu S; Plautz GE
Cancer Res; 2005 Oct; 65(20):9547-54. PubMed ID: 16230420
[TBL] [Abstract][Full Text] [Related]
14. Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic protein.
Kalbasi A; Shrimali RK; Chinnasamy D; Rosenberg SA
J Immunother; 2010 Sep; 33(7):672-83. PubMed ID: 20664359
[TBL] [Abstract][Full Text] [Related]
15. Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells.
Wrzesinski C; Paulos CM; Kaiser A; Muranski P; Palmer DC; Gattinoni L; Yu Z; Rosenberg SA; Restifo NP
J Immunother; 2010 Jan; 33(1):1-7. PubMed ID: 19952961
[TBL] [Abstract][Full Text] [Related]
16. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
17. Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors.
Cozza EM; Cooper TK; Budgeon LR; Christensen ND; Schell TD
Cancer Immunol Immunother; 2015 Mar; 64(3):325-36. PubMed ID: 25408469
[TBL] [Abstract][Full Text] [Related]
18. Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.
Hirai I; Funakoshi T; Kamijuku H; Fukuda K; Mori M; Sakurai M; Koda Y; Kato J; Mori T; Watanabe N; Noji S; Yaguchi T; Iwata T; Ohta S; Fujita T; Tanosaki R; Handa M; Okamoto S; Amagai M; Kawakami Y
Cancer Sci; 2021 Aug; 112(8):3163-3172. PubMed ID: 34101300
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.
Inoue M; Plautz GE; Shu S
Cancer Res; 1996 Oct; 56(20):4702-8. PubMed ID: 8840987
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
Dudley ME; Wunderlich J; Nishimura MI; Yu D; Yang JC; Topalian SL; Schwartzentruber DJ; Hwu P; Marincola FM; Sherry R; Leitman SF; Rosenberg SA
J Immunother; 2001; 24(4):363-73. PubMed ID: 11565838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]